Compared with filgotinib, adalimumab (4.81; 95% confidence interval [CI], 1.39-16.66), etanercept (6.04; 95% CI, 1.79-20.37), peficitinib (7.56; 95% CI, 1.63-35.12), tofacitinib (4.29; 95% CI, 1.43-12.88), and upadacitinib (4.35; 95% CI, 1.46-13.00) have an increased risk of herpes zoster infection. Risk differences between the drugs became…[Read more]

The mean age and mean DMFT of the dementia group versus the nondementia group were 80.9 ± 7.5 vs. 79.4 ± 6.7 (p = 0.428) and 22.5 ± 7.9 vs. 19.2 ± 9.3 (p = 0.041), respectively. There was no significant difference of periodontal status observed. The VPI of dementia and nondementia groups were 77% and 63%, respectively (p = 0.027). Though they had…[Read more]

The aim of the present research is to investigate the efficiency of surface-modified magnetic nanoparticles for photocatalytic degradation of PCBs from transformer oil. Therefore, CMCD-Fe3O4@TiO2 was successfully produced via grafting of carboxymethyl-β-cyclodextrin (CM-β-CD) onto the core-shell titania magnetic nanoparticles surface. The p…[Read more]